In this regard, oxidative stress‐induced angiogenesis depends on p53 mutation status and NF‐κB regulation, which provides novel strategies in the field of nanoparticle treatment for glioma angiogenesis. The gene discussed is NFKB1; the disease is central nervous system cancer.